LOXL2 and osteosarcoma: In this study, we sought to identify a mechanistic link between FGF-23 and the metastatic behavior of osteosarcoma cells, focusing on the miR-4463/LOXL2 axis and its effects in regulating the ERK, p38, and JNK signaling pathway.